Actionnariat et activité des initiés pour Pluri Inc. (PLUR): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $1.14 |
| Capitalisation | $12M |
| Bourse | NASDAQ |
| Pays | IL |
Bilan (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $4.7M | $8.8M | $4.1M | $8.8M | $31.2M | $9.8M | $5.4M | $6.8M | $5.9M | $3.5M |
| Placements à Court Terme | $21.4M | $21.1M | $19.6M | $37.5M | $33.7M | $45.2M | $34.8M | $23.2M | $14.7M | $4.3M |
| Créances | $1.2M | $847000 | $1.4M | $1.6M | $1.5M | $1.3M | $527000 | $638000 | $722000 | $219000 |
| Stocks | 0 | 0 | $692000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $29.0M | $32.0M | $26.4M | $48.5M | $67.4M | $57.7M | $41.4M | $31.1M | $22.1M | $8.7M |
| Immobilisations Corporelles | $7.3M | $5.7M | $3.8M | $3.8M | $2.2M | $9.0M | $8.3M | $7.2M | $8.7M | $7.7M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $3.1M | $3.1M |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $2.8M | $2.6M |
| Actifs Totaux | $37.5M | $39.0M | $31.3M | $65.5M | $93.5M | $68.1M | $50.8M | $39.5M | $38.7M | $24.9M |
| Dettes Fournisseurs | $2.0M | $3.3M | $2.3M | $2.0M | $2.5M | $1.8M | $1.8M | $964000 | $866000 | $702000 |
| Dette à Court Terme | 0 | 0 | 0 | $1.0M | 0 | 0 | 0 | 0 | $27.3M | $27.4M |
| Passifs Courants | $5.4M | $8.5M | $8.2M | $8.0M | $11.5M | $6.8M | $5.6M | $4.5M | $32.3M | $32.7M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | $23.9M | $21.7M | $23.5M | $24.0M | 0 | 0 |
| Passifs Totaux | $7.3M | $10.5M | $9.5M | $9.4M | $36.4M | $35.9M | $35.5M | $34.1M | $39.5M | $42.3M |
| Réserves | -$189.6M | -$215.7M | -$251.0M | -$280.2M | -$330.0M | -$371.3M | -$399.6M | -$420.5M | -$443.1M | -$466.9M |
| Capitaux Propres | $30.3M | $28.5M | $21.8M | $56.1M | $57.2M | $30.0M | $13.4M | $96000 | -$6.8M | -$23.0M |
| Dette Totale | 0 | 0 | 0 | $1.6M | $24.6M | $28.8M | $29.9M | $29.6M | $34.0M | $34.9M |
| Dette Nette | -$26.1M | -$29.9M | -$23.7M | -$44.8M | -$40.4M | -$26.2M | -$10.3M | -$373000 | $13.4M | $27.1M |
| Fonds de Roulement | $23.6M | $23.5M | $18.2M | $40.5M | $55.9M | $50.9M | $35.8M | $26.7M | -$10.2M | -$24.0M |
Santé financière
| Dette / Capitaux propres | -1.81 |
| Ratio de liquidité | 0.33 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -17.73 |
Rentabilité
| Rentabilité des capitaux propres | 203.55% |
| Rentabilité du capital investi | -117.79% |
| Rentabilité des actifs | -100.41% |
| Marge brute | 19.00% |
| Marge opérationnelle | -2412.14% |
| Marge nette | -2424.75% |
Entreprises liées: ANTX · BOLD · IBIO · INTS · ITRM · JSPR · NXTC
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de PLUR: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions